These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18604135)

  • 1. [Management of chronic hepatitis B in treatment-naive patients].
    Cheong JY
    Korean J Gastroenterol; 2008 Jun; 51(6):338-45. PubMed ID: 18604135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon in hepatitis B].
    García Buey L; González Mateos F; Moreno Otero R
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():19-31. PubMed ID: 19100228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs in development for hepatitis B.
    Buti M; Esteban R
    Drugs; 2005; 65(11):1451-60. PubMed ID: 16033287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH; Schalm SW; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New approaches in the treatment of hepatitis B].
    Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325
    [No Abstract]   [Full Text] [Related]  

  • 7. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of chronic hepatitis B.
    Hadziyannis SJ
    Expert Opin Biol Ther; 2006 Sep; 6(9):913-21. PubMed ID: 16918258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological agents for the treatment of chronic hepatitis B].
    Sánchez-Tapias JM
    Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of antiviral-resistant chronic hepatitis B virus infection].
    Yim HJ
    Korean J Gastroenterol; 2008 Jun; 51(6):346-59. PubMed ID: 18604136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes for patients with chronic hepatitis B.
    Gish RG
    Curr Gastroenterol Rep; 2007 Mar; 9(1):14-22. PubMed ID: 17335673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Malkowski P; Pawlowska M; Simon K;
    Pol Merkur Lekarski; 2010 Aug; 29(170):103-6. PubMed ID: 20842822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for chronic hepatitis B: a review.
    Palumbo E
    Am J Ther; 2008; 15(2):167-72. PubMed ID: 18356637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protocol for the antiviral therapy of chronic hepatitis B].
    ;
    Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.
    Marcellin P; Boyer N; Asselah T
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):23-38. PubMed ID: 16554704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.
    Hadziyannis SJ
    Expert Opin Investig Drugs; 2007 Jun; 16(6):777-86. PubMed ID: 17501691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment recommendations of chronic hepatitis B. Did the world escape us?].
    Flisiak R; Jaroszewicz J
    Przegl Epidemiol; 2008; 62(1):133-8. PubMed ID: 18536235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
    Viganò M; Invernizzi F; Lampertico P
    Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.
    Dienstag JL; Wei LJ; Xu D; Kreter B
    Clin Drug Investig; 2007; 27(1):35-49. PubMed ID: 17177578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.